Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00147823 · ClinicalTrials.gov registry record · NA
Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions
A NA study, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT00147823: Completed NA study, sponsored by State University of New York - Upstate Medical University.
NCT00147823 is a NA study that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00147823, a NA study, has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This is a prospective randomized study comparing Vitoss alone versus Vitoss with bone marrow aspirate in benign bone lesions.
Primary Outcome
Percentage of graft material that is resorbed (disappears) from area of incorporation, at 24 months .Participants were seen 24 month follow with radiographs to review resorption of graft material. There a several that had incomplete follow up or radiographs not taken.
Interventions
- DEVICE Vitoss Alone
- DEVICE Vitoss with Bone Marrow Aspirate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2004-12 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT00147823 record still lists
NCT00147823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Vitoss Alone is the first listed.
NCT00147823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00147823 about?
NCT00147823 is a clinical study titled "Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions". This is a prospective randomized study comparing Vitoss alone versus Vitoss with bone marrow aspirate in benign bone lesions.
What is the current status of trial NCT00147823?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2004-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00147823?
The interventions under investigation include: Vitoss Alone (DEVICE), Vitoss with Bone Marrow Aspirate (DEVICE).
Who is sponsoring clinical trial NCT00147823?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00147823's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia